Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Carnegie Fund - Medical Sub-Fund

+ Add to Watchlist

CARMEDI:LX

117.33 EUR 0.59 0.50%

As of 00:59:30 ET on 05/29/2015.

Snapshot for Carnegie Fund - Medical Sub-Fund (CARMEDI)

Year To Date: +23.64% 3-Month: +6.86% 3-Year: +34.07% 52-Week Range: 74.40 - 120.08
1-Month: +4.02% 1-Year: +58.73% 5-Year: +23.78% Beta vs LUXXX: 0.72

Mutual Fund Chart for CARMEDI

No chart data available.
  • CARMEDI:LX 117.33
  • 1M
  • 1Y
Interactive CARMEDI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CARMEDI

Carnegie Fund - Medical Sub-Fund is an FCP incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests globally in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors.

Inception Date: 12-18-1998 Telephone: 352-40-40-30-1
Managers: ANGELICA FATOUROS
Web Site: www.carnegie.se

Fundamentals for CARMEDI

NAV (on 2015-05-29) 117.33
Assets (M) (on 2015-04-30) 718.06
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for CARMEDI

No dividends reported

Fees & Expenses for CARMEDI

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.70
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CARMEDI

Filing Date: 04/30/2015
Name Position Value % of Total
Gilead Sciences Inc 529,672 48,393,192 6.739%
Novartis AG 410,862 37,829,568 5.268%
Johnson & Johnson 413,186 36,960,489 5.147%
UnitedHealth Group Inc 351,158 35,724,180 4.975%
Roche Holding AG 128,741 32,971,812 4.592%
Amgen Inc 228,638 32,766,658 4.563%
Pfizer Inc 1,036,315 31,619,701 4.403%
Carnegie Fund V - The Carnegie 85,642 29,719,394 4.139%
Celgene Corp 283,838 27,774,848 3.868%
Valeant Pharmaceuticals Intern 131,161 26,032,044 3.625%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil